Company intelligence / Profile preview

Altachem Pharma

Edmonton, Alberta, Canada

Ownership: Private
Development stage: Other

Overview

Altachem Pharma was a Canadian biopharmaceutical company based in Edmonton, Alberta, that specialized in the development of small molecule drugs for the treatment of cancer. The company's lead research program focused on Alta-236, a novel compound designed to inhibit tumor growth and metastasis in solid tumors. In June 2004, Altachem Pharma was acquired by ViRexx Pharmaceuticals in an all-stock transaction valued at approximately 4.5 million shares. The acquisition was intended to integrate Altachem's oncology assets into ViRexx's broader portfolio of immunotherapies and vaccines.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Altachem Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altachem Pharma.

Explore the full profile